Literature DB >> 27091718

Common susceptibility variants are shared between schizophrenia and psoriasis in the Han Chinese population.

Xianyong Yin1, Nathan E Wineinger1, Kai Wang1, Weihua Yue1, Nina Norgren1, Ling Wang1, Weiyi Yao1, Xiaoyun Jiang1, Bo Wu1, Yong Cui1, Changbing Shen1, Hui Cheng1, Fusheng Zhou1, Gang Chen1, Xianbo Zuo1, Xiaodong Zheng1, Xing Fan1, Hongyan Wang1, Lifang Wang1, Jimmy Lee1, Max Lam1, E Shyong Tai1, Zheng Zhang1, Qiong Huang1, Liangdan Sun1, Jinhua Xu1, Sen Yang1, Kirk C Wilhelmsen1, Jianjun Liu1, Nicholas J Schork1, Xuejun Zhang1.   

Abstract

BACKGROUND: Previous studies have shown that individuals with schizophrenia have a greater risk for psoriasis than a typical person. This suggests that there might be a shared genetic etiology between the 2 conditions. We aimed to characterize the potential shared genetic susceptibility between schizophrenia and psoriasis using genome-wide marker genotype data.
METHODS: We obtained genetic data on individuals with psoriasis, schizophrenia and control individuals. We applied a marker-based coheritability estimation procedure, polygenic score analysis, a gene set enrichment test and a least absolute shrinkage and selection operator regression model to estimate the potential shared genetic etiology between the 2 diseases. We validated the results in independent schizophrenia and psoriasis cohorts from Singapore.
RESULTS: We included 1139 individuals with psoriasis, 744 with schizophrenia and 1678 controls in our analysis, and we validated the results in independent cohorts, including 441 individuals with psoriasis (and 2420 controls) and 1630 with schizophrenia (and 1860 controls). We estimated that a large fraction of schizophrenia and psoriasis risk could be attributed to common variants (h2SNP = 29% ± 5.0%, p = 2.00 × 10-8), with a coheritability estimate between the traits of 21%. We identified 5 variants within the human leukocyte antigen (HLA) gene region, which were most likely to be associated with both diseases and collectively conferred a significant risk effect (odds ratio of highest risk quartile = 6.03, p < 2.00 × 10-16). We discovered that variants contributing most to the shared heritable component between psoriasis and schizophrenia were enriched in antigen processing and cell endoplasmic reticulum. LIMITATIONS: Our sample size was relatively small. The findings of 5 HLA gene variants were complicated by the complex structure in the HLA region.
CONCLUSION: We found evidence for a shared genetic etiology between schizophrenia and psoriasis. The mechanism for this shared genetic basis likely involves immune and calcium signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27091718      PMCID: PMC5082512          DOI: 10.1503/jpn.150210

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  41 in total

1.  Increased risk of psoriasis among patients with schizophrenia: a nationwide population-based study.

Authors:  Y-W Yang; H-C Lin
Journal:  Br J Dermatol       Date:  2012-04       Impact factor: 9.302

2.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder.

Authors:  Peter Holmans; Elaine K Green; Jaspreet Singh Pahwa; Manuel A R Ferreira; Shaun M Purcell; Pamela Sklar; Michael J Owen; Michael C O'Donovan; Nick Craddock
Journal:  Am J Hum Genet       Date:  2009-06-18       Impact factor: 11.025

3.  Common SNPs explain a large proportion of the heritability for human height.

Authors:  Jian Yang; Beben Benyamin; Brian P McEvoy; Scott Gordon; Anjali K Henders; Dale R Nyholt; Pamela A Madden; Andrew C Heath; Nicholas G Martin; Grant W Montgomery; Michael E Goddard; Peter M Visscher
Journal:  Nat Genet       Date:  2010-06-20       Impact factor: 38.330

4.  Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci.

Authors:  David Ellinghaus; Eva Ellinghaus; Rajan P Nair; Philip E Stuart; Tõnu Esko; Andres Metspalu; Sophie Debrus; John V Raelson; Trilokraj Tejasvi; Majid Belouchi; Sarah L West; Jonathan N Barker; Sulev Kõks; Külli Kingo; Tobias Balschun; Orazio Palmieri; Vito Annese; Christian Gieger; H Erich Wichmann; Michael Kabesch; Richard C Trembath; Christopher G Mathew; Gonçalo R Abecasis; Stephan Weidinger; Susanna Nikolaus; Stefan Schreiber; James T Elder; Michael Weichenthal; Michael Nothnagel; Andre Franke
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

5.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

6.  Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia.

Authors:  J G Knight
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

Review 7.  Vitamin D and the skin.

Authors:  Masahiro Kira; Teruaki Kobayashi; Kunihiko Yoshikawa
Journal:  J Dermatol       Date:  2003-06       Impact factor: 4.005

Review 8.  Genetic liability for schizophrenia predicts risk of immune disorders.

Authors:  Sven Stringer; René S Kahn; Lot D de Witte; Roel A Ophoff; Eske M Derks
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

9.  Genome-wide association analysis identifies 13 new risk loci for schizophrenia.

Authors:  Stephan Ripke; Colm O'Dushlaine; Kimberly Chambert; Jennifer L Moran; Anna K Kähler; Susanne Akterin; Sarah E Bergen; Ann L Collins; James J Crowley; Menachem Fromer; Yunjung Kim; Sang Hong Lee; Patrik K E Magnusson; Nick Sanchez; Eli A Stahl; Stephanie Williams; Naomi R Wray; Kai Xia; Francesco Bettella; Anders D Borglum; Brendan K Bulik-Sullivan; Paul Cormican; Nick Craddock; Christiaan de Leeuw; Naser Durmishi; Michael Gill; Vera Golimbet; Marian L Hamshere; Peter Holmans; David M Hougaard; Kenneth S Kendler; Kuang Lin; Derek W Morris; Ole Mors; Preben B Mortensen; Benjamin M Neale; Francis A O'Neill; Michael J Owen; Milica Pejovic Milovancevic; Danielle Posthuma; John Powell; Alexander L Richards; Brien P Riley; Douglas Ruderfer; Dan Rujescu; Engilbert Sigurdsson; Teimuraz Silagadze; August B Smit; Hreinn Stefansson; Stacy Steinberg; Jaana Suvisaari; Sarah Tosato; Matthijs Verhage; James T Walters; Douglas F Levinson; Pablo V Gejman; Kenneth S Kendler; Claudine Laurent; Bryan J Mowry; Michael C O'Donovan; Michael J Owen; Ann E Pulver; Brien P Riley; Sibylle G Schwab; Dieter B Wildenauer; Frank Dudbridge; Peter Holmans; Jianxin Shi; Margot Albus; Madeline Alexander; Dominique Campion; David Cohen; Dimitris Dikeos; Jubao Duan; Peter Eichhammer; Stephanie Godard; Mark Hansen; F Bernard Lerer; Kung-Yee Liang; Wolfgang Maier; Jacques Mallet; Deborah A Nertney; Gerald Nestadt; Nadine Norton; Francis A O'Neill; George N Papadimitriou; Robert Ribble; Alan R Sanders; Jeremy M Silverman; Dermot Walsh; Nigel M Williams; Brandon Wormley; Maria J Arranz; Steven Bakker; Stephan Bender; Elvira Bramon; David Collier; Benedicto Crespo-Facorro; Jeremy Hall; Conrad Iyegbe; Assen Jablensky; Rene S Kahn; Luba Kalaydjieva; Stephen Lawrie; Cathryn M Lewis; Kuang Lin; Don H Linszen; Ignacio Mata; Andrew McIntosh; Robin M Murray; Roel A Ophoff; John Powell; Dan Rujescu; Jim Van Os; Muriel Walshe; Matthias Weisbrod; Durk Wiersma; Peter Donnelly; Ines Barroso; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden P Corvin; Panos Deloukas; Audrey Duncanson; Janusz Jankowski; Hugh S Markus; Christopher G Mathew; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Richard C Trembath; Ananth C Viswanathan; Nicholas W Wood; Chris C A Spencer; Gavin Band; Céline Bellenguez; Colin Freeman; Garrett Hellenthal; Eleni Giannoulatou; Matti Pirinen; Richard D Pearson; Amy Strange; Zhan Su; Damjan Vukcevic; Peter Donnelly; Cordelia Langford; Sarah E Hunt; Sarah Edkins; Rhian Gwilliam; Hannah Blackburn; Suzannah J Bumpstead; Serge Dronov; Matthew Gillman; Emma Gray; Naomi Hammond; Alagurevathi Jayakumar; Owen T McCann; Jennifer Liddle; Simon C Potter; Radhi Ravindrarajah; Michelle Ricketts; Avazeh Tashakkori-Ghanbaria; Matthew J Waller; Paul Weston; Sara Widaa; Pamela Whittaker; Ines Barroso; Panos Deloukas; Christopher G Mathew; Jenefer M Blackwell; Matthew A Brown; Aiden P Corvin; Mark I McCarthy; Chris C A Spencer; Elvira Bramon; Aiden P Corvin; Michael C O'Donovan; Kari Stefansson; Edward Scolnick; Shaun Purcell; Steven A McCarroll; Pamela Sklar; Christina M Hultman; Patrick F Sullivan
Journal:  Nat Genet       Date:  2013-08-25       Impact factor: 38.330

10.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

View more
  5 in total

Review 1.  Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.

Authors:  Ryan Bogdan; David A A Baranger; Arpana Agrawal
Journal:  Annu Rev Clin Psychol       Date:  2018-05-07       Impact factor: 18.561

Review 2.  Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia.

Authors:  Monojit Debnath; Michael Berk
Journal:  Mol Neurobiol       Date:  2016-11-29       Impact factor: 5.590

3.  Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.

Authors:  Jennie G Pouget; Buhm Han; Yang Wu; Emmanuel Mignot; Hanna M Ollila; Jonathan Barker; Sarah Spain; Nick Dand; Richard Trembath; Javier Martin; Maureen D Mayes; Lara Bossini-Castillo; Elena López-Isac; Ying Jin; Stephanie A Santorico; Richard A Spritz; Hakon Hakonarson; Constantin Polychronakos; Soumya Raychaudhuri; Jo Knight
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

4.  Psychiatric Genetics, Epigenetics, and Cellular Models in Coming Years.

Authors:  Chunyu Liu; Stephen V Faraone; Stephen J Glatt
Journal:  J Psychiatr Brain Sci       Date:  2019-08-22

Review 5.  Cognitive Process of Psoriasis and Its Comorbidities: From Epidemiology to Genetics.

Authors:  Jing Gao; Xue Shen; Randy Ko; Cong Huang; Changbing Shen
Journal:  Front Genet       Date:  2021-11-26       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.